JSM2026
Back to all people

Zhili Qiao

Eli Lilly and Company
1 appearance in the program

Sessions & presentations

To See the Unseen: Advancing Drug Development through the Lens of Causal Inference
Presentation: Separating Signal from Adherence: Causal Decomposition for Bridging Phase 2 and Phase 3 Estimands
Topic-Contributed Paper Session · Mon, Aug 3 , 2:00 PM
Speaker